COMPANIES COVERED
AbbottDownload FREE Report Sample
Download Free sampleChlamydia Diagnostic Testing is used to screen for, diagnose, and verify successful treatment of infections caused by the bacteria Chlamydia trachomatis.
Chlamydia Diagnostic Testing Market contains market size and forecasts of Chlamydia Diagnostic Testing in Global, including the following market information:
Global Chlamydia Diagnostic Testing Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global top five companies in 2021 (%)
The global Chlamydia Diagnostic Testing market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Nucleic Acid Amplification Tests (NAATs) Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Chlamydia Diagnostic Testing include Abbott, ADI/American Diagnostica, Agilent Technologies, Chrono-Log, Corgenix, Decode Genetics, Diadexus, Diagnocure and Diagnostica Stago/Trinity Biotech, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
We surveyed the Chlamydia Diagnostic Testing companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Chlamydia Diagnostic Testing Market, by Type, 2017-2022, 2023-2028 ($ millions)
Global Chlamydia Diagnostic Testing Market Segment Percentages, by Type, 2021 (%)
Nucleic Acid Amplification Tests (NAATs)
Direct Fluorescent Tests
Global Chlamydia Diagnostic Testing Market, by Application, 2017-2022, 2023-2028 ($ millions)
Global Chlamydia Diagnostic Testing Market Segment Percentages, by Application, 2021 (%)
Hospitals
Commercial/Private Labs
Physician Offices
Public Health Labs
Global Chlamydia Diagnostic Testing Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)
Global Chlamydia Diagnostic Testing Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Chlamydia Diagnostic Testing revenues in global market, 2017-2022 (estimated), ($ millions)
Key companies Chlamydia Diagnostic Testing revenues share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Abbott
ADI/American Diagnostica
Agilent Technologies
Chrono-Log
Corgenix
Decode Genetics
Diadexus
Diagnocure
Diagnostica Stago/Trinity Biotech
Diamedix
International Technidyne/Nexus DX
Kreatech/Leica
Polymedco
Qiagen
Roche
SDIX
Sequenom
Siemens
Speak to our Custom Research Team and get the Custom Research in a budget
Custom ResearchFrequently Asked Questions ?
A license granted to one user. Rules or conditions might be applied for e.g. the use of electric files (PDFs) or printings, depending on product.
A license granted to multiple users.
A license granted to a single business site/establishment.
A license granted to all employees within organisation access to the product.
Upto Working 24 to 48 hrs
Upto 72 hrs max - Weekends and Public Holidays
Online Payments with PayPal and CCavenue
Wire Transfer/Bank Transfer
Hard Copy
Industry Market SizeSWOT AnalysisIndustry Major PlayersRevenue ForecastsHistorical and Forecast GrowthProfitability Analysis
